Brent Guidelines for the Care of People with Diabetes
Second Version
Treatment Plan For Lipid Lowering In Type 2 Diabetes
ALL PATIENTS WITH TYPE 2 DIABETES SHOULD BE ON A STATIN TO REDUCE THEIR CARDIOVASCULAR RISK INDEPENDENT OF THEIR LIPID PROFILE UNLESS THEY HAVE A SPECIFIC CONTRAINDICATION (SEE BNF) TARGETS TO ACHIEVE TO REDUCE CV RISK WITHOUT CV EVENT
CHOLESTEROL LDL TRIGLYCERIDES
<5 <3 < 2.3
ALL TYPE 2 DIABETES PATIENTS WITHOUT A CV EVENT LIFE STYLE ISSUES NEED TO BE ADDRESSED CONCURRENTLY
CHOLESTEROL > 6 OR LDL > 3.5
CHOLESTEROL < 6 OR LDL <3.5
Start Rosuvastatin 10mg od or Atorvastatin 10mg – 40mg
Start Simvastatin 20mg-40mg od or Atorvastatin 10mg – 40mg od or Rosuvastatin 10mg od
After 3/12 FOLLOW BELOW IF TARGET NOT ACHIEVED
Add Fenofibrate 160 -267mg od if triglycerides are still > 2.3 ( despite HbA1c <8%) Add Ezetimibe 10mg od if patient unable to tolerate higher doses of statin If HDL < 1.2 before starting treatment higher doses of statin can reduce this except Rosuvastatin contact Single Point Access for Diabetes Care for further advice
“Working with our partners for a healthier Brent”
1